SCHEMBL13849652

SCHEMBL13849652

COc1cnc2c(c1)c(C(=O)c1cn(-c3ccccn3)nn1)cn2Cc1ccc(Cl)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 3/20 0.39
NR3C1 P04150 2/20 0.38
ACHE P22303 1/20 0.38
CFD P00746 1/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ESRRA P11474 1/20 0.36
SPR P35270 1/20 0.36
PTPN11 Q06124 1/20 0.36
KDM4E B2RXH2 2/20 0.35
CHRM1 P11229 1/20 0.35
NPY1R P25929 1/20 0.35
HTT P42858 1/20 0.35
NPY2R P49146 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13849711 0.90 ESRRA (0.43) AHRMAPTLMNANR3C1ALDH1A1
SCHEMBL2007308 0.87 LMNA (0.52) AHRMAPTLMNAACHEALDH1A1
SCHEMBL13849675 0.78 MEN1 (0.47) AHRMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL2009190 0.78 LMNA (0.51) AHRMAPTLMNAACHEALDH1A1
SCHEMBL2007527 0.78 LMNA (0.47) AHRMAPTLMNAACHEALDH1A1
SCHEMBL3010625 0.78 PDE4A (0.47) MAPTNR3C1CFDALDH1A1SMN1; SMN2
SCHEMBL2002244 0.77 LMNA (0.49) AHRMAPTLMNAACHEALDH1A1
SCHEMBL2001750 0.77 PLA2G2A (0.50) MAPTLMNAACHEALDH1A1TSHR
SCHEMBL13849670 0.76 MEN1 (0.45) MAPTLMNANR3C1ALDH1A1SMN1; SMN2
SCHEMBL2004180 0.76 LMNA (0.51) AHRMAPTLMNAACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 AHR 27/4885MAPT 2737/4885LMNA 4089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.